Insider · CIK 0001815366
Michael Zinda
Files at RPTX (Repare Therapeutics Inc.). First filing Mar 27, 2024, latest Mar 27, 2024.
In brief
Michael Zinda files SEC Form 4 as officer at RPTX (Repare Therapeutics Inc.). Since Mar 27, 2024, Michael Zinda has reported 0 open-market buys worth $0 and 1 open-market sell worth $6,305, the latest filed on Mar 27, 2024.
A track record needs three past buys with six months of prices behind them; Michael Zinda has 0, so none is measured yet.
The newest scored trade: sold $6,305 of RPTX on Mar 25, 2024, filed Mar 27, 2024, scored 10 (weak), under a 10b5-1 plan.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | Repare Therapeutics Inc. | $6,305 1,350 shares | -2% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 25, 2024 | RPTX REPARE THERAPEUTICS INC | 2,210 0.01% of outstanding | $11k | Mar 25, 2024 | none |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 25, 2024 | RPTX Repare Therapeutics Inc. | SOpen-market sale Common Shares10b5-1 | -450 | $4.78 | $2,151 | 73,668 | Mar 27, 2024 |
| Mar 26, 2024 | RPTX Repare Therapeutics Inc. | SOpen-market sale Common Shares10b5-1 | -450 | $4.61 | $2,075 | 73,218 | Mar 27, 2024 |
| Mar 27, 2024 | RPTX Repare Therapeutics Inc. | SOpen-market sale Common Shares10b5-1 | -450 | $4.62 | $2,079 | 72,768 | Mar 27, 2024 |
| Mar 1, 2024 | RPTX Repare Therapeutics Inc. | AGrant or award Common Shares | +14,000 | $0.00 | $0 | 74,118 | Mar 4, 2024 |
| Mar 1, 2024 | RPTX Repare Therapeutics Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +85,000 | $0.00 | $0 | 85,000 | Mar 4, 2024 |
Questions about Michael Zinda
Answered from the filings on this page, as of the latest one.
Is Michael Zinda buying or selling?
Not in the last 12 months. Michael Zinda's latest open-market trade on SEC Form 4 was sold $6,305 of RPTX on Mar 25, 2024.
How did Michael Zinda's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael Zinda has 0.
Where does Michael Zinda file Form 4?
Michael Zinda has filed Form 4 at RPTX (Repare Therapeutics Inc.) as EVP, CHIEF SCIENTIFIC OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.